UnitedHealth Group (NYSE:UNH) Price Target Raised to $524.00

UnitedHealth Group (NYSE:UNH) had its price target lifted by JPMorgan Chase & Co. from $516.00 to $524.00 in a report issued on Friday,Benzinga reports. The firm currently has an overweight rating on the healthcare conglomerate’s stock.

UNH has been the topic of several other reports. Piper Sandler increased their price objective on shares of UnitedHealth Group from $502.00 to $504.00 and gave the company an “overweight” rating in a report on Wednesday, October 14th. UBS Group reissued an “outperform” rating on shares of UnitedHealth Group in a research note on Tuesday, October 13th. KeyCorp restated an “overweight” rating on shares of UnitedHealth Group in a research report on Wednesday. Royal Bank Of Canada raised their price target on shares of UnitedHealth Group from $463.00 to $478.00 and gave the company an “outperform” rating in a research note on Friday, July 17th. Finally, Morgan Stanley lifted their price objective on UnitedHealth Group from $468.00 to $529.00 and gave the stock an “overweight” rating in a report on Friday, July 17th. Twenty investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $462.90.

UnitedHealth Group Stock Up 0.1%

UnitedHealth Group stock opened at $401.77 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.78. The stock has a market capitalization of $360.62 billion, a PE ratio of 22.95, a price-to-earnings-growth ratio of 1.45 and a beta of 0.60. The business has a 50 day simple moving average of $387.07 and a 200-day simple moving average of $385.50. UnitedHealth Group has a 12 month low of $255.96 and a 12 month high of $461.62.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.14 by $0.55. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The firm had revenue of $112.70 billion for the quarter, compared to analyst estimates of $111.31 billion. During the same quarter last year, the firm posted $2.59 EPS. The business’s revenue was down .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, analysts anticipate that UnitedHealth Group will post 20.64 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th were paid a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a yield of 2.3%. The ex-dividend date of this dividend was Monday, September 14th. UnitedHealth Group’s payout ratio is 53.00%.

Insider Transactions at UnitedHealth Group

In other news, CEO Patrick Conway sold 1,169 shares of the company’s stock in a transaction on Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the sale, the chief executive officer owned 15,328 shares of the company’s stock, valued at $5,977,920. This represents a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.19% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On UnitedHealth Group

A number of institutional investors and hedge funds have recently bought and sold shares of UNH. Onyx Bridge Wealth Group LLC increased its position in shares of UnitedHealth Group by 4.3% during the third quarter. Onyx Bridge Wealth Group LLC now owns 678 shares of the healthcare conglomerate’s stock worth $249,000 after acquiring an additional 28 shares during the last quarter. SteelPeak Wealth LLC lifted its stake in shares of UnitedHealth Group by 41.9% in the third quarter. SteelPeak Wealth LLC now owns 45,834 shares of the healthcare conglomerate’s stock worth $16,825,000 after acquiring an additional 13,533 shares in the last quarter. Founders Grove Wealth Partners LLC purchased a new position in UnitedHealth Group in the third quarter valued at about $294,000. Finer Wealth Management Inc. grew its stake in UnitedHealth Group by 11.2% during the 3rd quarter. Finer Wealth Management Inc. now owns 2,418 shares of the healthcare conglomerate’s stock valued at $888,000 after purchasing an additional 243 shares in the last quarter. Finally, Encompass More Asset Management acquired a new stake in UnitedHealth Group during the 3rd quarter valued at approximately $1,903,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Q3 results and guidance exceeded expectations. UnitedHealth reported adjusted earnings of $4.69 per share versus the $4.14 consensus estimate, while revenue of $112.7 billion also topped forecasts. Management raised its 2026 adjusted EPS outlook to at least $20.50, supporting the recovery narrative. UnitedHealth Stock Moves Higher: What’s Going On?
• Positive Sentiment: Analyst support remains significant. JPMorgan raised its price target to $524 and maintained an “overweight” rating, while Goldman Sachs reportedly lifted its target to $506 after concluding that Medicare Advantage margin recovery is progressing faster than expected. JPMorgan Raises UnitedHealth Price Target
• Positive Sentiment: Potential growth areas could support 2027 and beyond. UnitedHealth’s focus on Medicare special-needs plans, expanded coverage and care-delivery operations may provide targeted growth while improving margins. Its low beta also makes UNH attractive as a defensive healthcare holding during inflation and market rotation away from technology stocks. Can UNH’s Focus on Special Needs Plans Strengthen Medicare Growth?
• Neutral Sentiment: Recent gains may have already priced in much of the good news. Commentary noted that the earnings beat and outlook increase were followed by questions about how durable the recovery will be, limiting the immediate upside despite bullish targets. UnitedHealth Beats on Earnings, But Investors Question Growth Path
• Negative Sentiment: Membership fell and medical costs remain high. Analysts are concerned that shrinking membership and elevated utilization could constrain revenue growth and margins, particularly if higher care costs persist. This is the main reason investors are questioning whether the earnings improvement can continue. UnitedHealth’s Q3 Margins Improve, But Membership Falls
• Negative Sentiment: Analyst views are mixed. Barclays issued a pessimistic forecast, Robert W. Baird cut its price target, and TD Cowen reiterated a “hold” rating with a $402 target, signaling limited near-term upside for some investors.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.